Search Results
May 28, 2026, 08:30 ET Strengthen Participant-Site Readiness for Complex Rare Disease Trials, Upcoming Webinar Hosted by Xtalks
site partnerships can reduce participant burden, strengthen site engagement and support better outcomes in complex trials.Join Florence Mowlem, PhD, Chief Scientific Officer,
More news about: Xtalks
May 28, 2026, 08:30 ET Prevent Advanced Therapy Program Delays with Early Supply Chain Strategy, Upcoming Webinar Hosted by Xtalks
reduce downstream risk.Join Lorraine Hicks, Supply Chain & Clinical Logistics Expert / Cell & Gene Therapy Specialist; Dominic Clarke, PhD, Associate Chief Scientific Officer, Cryoport, Inc. / Vice President - Technical Operations, Integricell®, Cryoport Systems; and Gwendolyn Erskine, Senior
More news about: Xtalks
May 28, 2026, 08:15 ET Psilera Closes Oversubscribed $8.8M Seed Funding Round to Accelerate Neuroplastogen PSIL-006 Into the Clinic
several significant milestones, including:The appointment of distinguished neuroscience industry expert Magali Haas, MD/PhD, as Chief Medical Officer;Receipt of an NIH funding award of up to $2 million for IND-enabling studies of PSIL-006 in alcohol use disorder
More news about: Psilera, Inc.
May 28, 2026, 07:05 ET Novel Spanish, Culturally Adapted Metastatic Breast Cancer Symptom Management Guide Debuts at ASCO 2026
represents an important step in ensuring Hispanic and Latina patients feel seen, informed, empowered, and supported," said Dr. Veronica Vital, PhD, MSN, MLS, RN, President, National Association of Hispanic Nurses (NAHN).Developed in collaboration with individuals living with MBC, bilingual
More news about: Viver Health
May 27, 2026, 14:00 ET American Council of Learned Societies Announces 2026 Awardees of The Robert H. N. Ho Family Foundation Program in Buddhist Studies
Courtauld Institute of Art (London, England), and The Tricycle Foundation (New York, NY). These fellows will apply their academic expertise from their PhD training to strengthen the host organization's presentation of Buddhist art, thought, and practice to broad audiences.
More news about: American Council of Learned Societies
May 27, 2026, 12:44 ET NATIONAL GRASSROOTS MOVEMENT DEMANDS ACTION ON SKYROCKETING COST OF U.S. HEALTHCARE
pray."When people in America are forced to choose between buying groceries or seeing their doctor, it's a problem that requires action," said Avenel Joseph, PhD, vice president for policy at the Robert Wood Johnson Foundation. "The time to demand action is now. All of us who are frustrated by the status quo must
More news about: Robert Wood Johnson Foundation
May 27, 2026, 12:37 ET Post-ASCO 2026 Insights: Trial Development and Execution Strategies, Upcoming Webinar Hosted by Xtalks
Register for this webinar to learn how ASCO 2026 insights can inform oncology trial development and execution strategies.Join Andrew Zupnick, PhD, VP, Oncology Drug Development,
More news about: Xtalks
May 27, 2026, 11:11 ET CellCarta and Sonic Healthcare Establish Strategic Partnership to Commercialize Companion Diagnostics Through Lab Network
www.sonichealthcareusa.comMedia ContactsCellCartaStéphanie Bussières-Marmen, PhDDirector, Global [email protected]
More news about: CellCarta
May 27, 2026, 10:41 ET HEALEY ALS Platform Trial Regimen I expands to 240 participants
accelerate progress, strengthen the research ecosystem, and ultimately deliver solutions that better serve the ALS community."Sabrina Paganoni, MD, PhD, Co-Principal Investigator of the HEALEY ALS Platform Trial and Co-Director of the Neurological Clinical Research Institute (NCRI) said: "I want
More news about: Neurizon Therapeutics Limited
May 27, 2026, 10:30 ET Dr. Rebecca A Sager Named Recipient of PICI's Inaugural Endowed Young Investigator Award
May 27, 2026 /PRNewswire/ -- The Parker Institute for Cancer Immunotherapy (PICI) today announced that Dr. Rebecca A. Sager, MD, PhD, urologic oncology fellow at Memorial Sloan Kettering Cancer Center, has been named the inaugural recipient of the Conquer Cancer - Parker Institute
More news about: Parker Institute for Cancer Immunotherapy
May 27, 2026, 10:01 ET FORT Robotics Acquires Mapless AI to Expand Its Trust Platform with Remote Supervision and Active Safety Capabilities
intact.A Powerhouse of Automotive and Deep-Tech ExpertiseThe Mapless AI team, led by founders Philipp Robbel, PhD (MIT), and Jeffrey Kane Johnson, PhD (Indiana University), draws on deep roots in automotive leadership, including Bosch, Apple, Uber, Aptiv and nuTonomy. Their rare combination
More news about: FORT Robotics
May 27, 2026, 10:01 ET FORT Robotics Acquires Mapless AI to Expand Its Trust Platform with Remote Supervision and Active Safety Capabilities
intact.A Powerhouse of Automotive and Deep-Tech ExpertiseThe Mapless AI team, led by founders Philipp Robbel, PhD (MIT), and Jeffrey Kane Johnson, PhD (Indiana University), draws on deep roots in automotive leadership, including Bosch, Apple, Uber, Aptiv and nuTonomy. Their rare combination
More news about: FORT Robotics
May 27, 2026, 10:00 ET Linus Health Digital Cognitive Assessments Meet or Surpass New CEOi Benchmarks for Early Cognitive Impairment Detection
likely."Clear, clinically relevant standards are essential for moving digital cognitive assessment from promise to routine practice," said David Bates, PhD, CEO and co-founder of Linus Health. "The CEOi's recommendations reinforce the direction we have believed in from the beginning: brief, scalable, scientifically
More news about: Linus Health
May 27, 2026, 10:00 ET Debut and Natura Partner to Commercialize AI-Discovered Skin Longevity Ingredient for Latin America
beauty innovation where advanced science and nature work in synergy to deliver a new standard of clinically validated performance," said Joshua Britton, PhD, Founder and CEO, Debut. "By combining genomics-enabled molecular design with Natura's unique heritage in botanical actives from the Amazon, we are unlocking
More news about: Debut Biotechnology
May 27, 2026, 09:45 ET CenExel highlights industry-leading capabilities amid growing FDA momentum advancing psychedelic clinical research
research."Psychedelic therapies represent one of the most promising emerging areas in investigational treatments for population mental health," said Alex Kelman, PhD, Psychedelic Facilitator for CenExel. "Given the substantial unmet need across so many mental health conditions, bringing rigorous scientific attention
More news about: CenExel Clinical Research
May 27, 2026, 09:30 ET Global Clean Energy Inc. Acquires AI for Natural Disasters to Expand Disaster Prediction and Emergency Response Platform.
quickly."Natural disasters are increasing in frequency and severity and the underlying risk intelligence infrastructure hasn't kept pace," said Thomas Roderick PhD, CTO. "Available tools on the market are coarse, siloed, and typically static. TerraVigil is designed to be the foundational layer to predict disaster
More news about: Global Clean Energy Inc.
May 27, 2026, 09:07 ET MiniMed to Showcase MiniMed Flex™ and MiniMed Go™ at the American Diabetes Association Scientific Sessions
6, 12:30-1:30 p.m. CT in Theater B, featuring Anuj Bhargava, MD, MBA, CDCES, FACP, FACE CEO & Medical Director Iowa Diabetes and Johan Jendle, MD PhD Professor of Medicine Institute of Medical Sciences, Örebro University, Director for the Diabetes Endocrinology and Metabolism Research Center.Learning
More news about: MiniMed
May 27, 2026, 08:38 ET Sychedelic Closes $3.5 Million Seed Round to Launch the First Closed-Loop Neurostimulation Headphones
technology.3-in-1 Lifestyle Device: Combines music, wellness and adaptive neurotechnology in one wearable.Giuseppina Pilloni, PhD, and Assistant Professor at the NYU Grossman School of Medicine, affirms Sychedelic's approach and the power of Neurotechnology to help individuals optimize
More news about: Sychedelic
May 27, 2026, 08:27 ET The American Diabetes Association Debuts the 2026 Scientific Sessions, Driving the Future of Diabetes Care
comes at a defining moment for diabetes and obesity research, where discovery is rapidly translating into real-world impact," said Marlon Pragnell, PhD, the ADA's vice president of research & science. "From potential diabetes cures to next-generation obesity treatments, this meeting will challenge
More news about: American Diabetes Association
May 27, 2026, 08:15 ET Annals of Family Medicine: Researchers in China Examine Use of AI-Assisted Ultrasound by General Practitioners To Detect Carotid Artery Plaque
Detection Using AI-Enhanced Point-of-Care Ultrasound After Systematic TrainingXiaochuan Liu, MD; Sichen Yao, BS; Hua Yang, Phd; and Zhigang Pan, PhdFunding: This study was supported by the Shanghai Municipal Health Commission Key Supported Discipline Construction (General Practice
More news about: Annals of Family Medicine
May 27, 2026, 08:00 ET Coalition for Health AI (CHAI) Releases Comprehensive Governance Playbooks to Streamline AI Implementation for Health Systems
will soon release."We wanted to make sure the playbooks reflected the realities of the organizations that would use them," said Merage Ghane, PhD, Director of Responsible AI at CHAI. "What are the challenges, lessons learned, and resources needed to make responsible AI actionable, were just a few
More news about: Coalition for Health AI
May 27, 2026, 07:00 ET Precigen Receives Orphan Drug Exclusivity for PAPZIMEOS (zopapogene imadenovec-drba) in the United States
groundbreaking pivotal study data and the transformative potential of PAPZIMEOS in addressing the root cause of this rare disease," said Helen Sabzevari, PhD, President and CEO of Precigen. "This regulatory exclusivity, together with Precigen's patent portfolio covering PAPZIMEOS and its therapeutic use, enhances
More news about: Precigen, Inc.
May 27, 2026, 03:00 ET Society of Hematologic Oncology opens registration for case-based MDS/AML program ahead of SOHO 2026
MDCourtney D. DiNardo, MD, MSCEAmir Fathi, MDRami S. Komrokji, MDSangeetha Venugopal, MD, MSAndrew Wei, MBBS, PhDFor a full list of speakers and sessions, visit the
More news about: Society of Hematologic Oncology
May 26, 2026, 13:37 ET New Study Conducted at Sheppard Pratt Finds Psilocybin-Assisted Therapy May Reduce Chronic Suicidal Ideation
and treatment-resistant depression. The study, led by Scott T. Aaronson, MD, chief science officer at Sheppard Pratt with Andrew van der Vaart, MD, PhD, psychiatrist at Sheppard Pratt, as first author, provides early evidence that a single dose of psilocybin administered with psychological support may
More news about: Sheppard Pratt
May 26, 2026, 13:28 ET Data analysis by ECRI on patient falls reveals common risk factors
alarms or checklists; it requires understanding how care is actually delivered and experienced in real clinical environments," said Polly Tremoulet, PhD, Director of Human Factors Engineering at ECRI. "When we apply human factors-based systems thinking after a fall or near-miss, we seek to understand
More news about: ECRI